MEDIBIO COMPLETES HEAVILY OVERSUBSCRIBED INSTITUTIONAL PLACEMENT FOR $13.9 MILLION TO ACCELERATE COMMERCIALISATION

Highlights:
- Placement completed, with oversubscriptions accepted up to $13.9 Million
- Fidelity Investments follows on to maintain 10.6% ownership of the Company
- IFM Investors and Regal FM to become substantial shareholders post-transaction
- Medibio now fully funded to pursue aggressive commercialisation and IP strategy

SYDNEY, Australia and MINNEAPOLIS, Oct 13 (Bernama-GLOBE NEWSWIRE) -- Medibio Limited (ASX:MEB)(OTCQB:MDBIF) is pleased to announce that it has received firm commitments to raise $13.9 million via the placement of 38,736,640 ordinary shares at a price of $0.36 per share.  The placement will be conducted in a single tranche using the Company’s existing placement capacity under ASX Listing Rule 7.1 and 7.1A.

http://mrem.bernama.com/viewsm.php?idm=30295